Hematopoietic Stem Cell Transplantation for CNS Autoimmune Disorders for Adults and Children: Long-Term Outcomes - Experience of the Russian Federation

Kirill Kirgizov,Elena Skorobogatova,Denis Fedorenko,Elvira Volkova,Alexey Polushin,Ekaterina Pristanskova,Oksana Blagonravova,Sergey Piliya,Raisa Bembeeva,Ludmila Zubarovskaya,Axel Zander,Boris Afanasyev,Alexander Rumyantsev

Blood（2018）

引用 0|浏览13

暂无评分

摘要

Rationale. More than 70 000 of patients registered with multiple sclerosis (MS) registered in Russia annually. Some of adults and children with CNS autoimmune disorder (AD) require hematopoietic stem cell transplantation (HSCT). We analyzed long-term outcomes and late effects in adults and children with MS and neuromyelitis optica (NMO) after HSCT treated in three Russian centers.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要